Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Paragon 28 (FNA) Investors to Inquire About a Securities Fraud Class Action by November 29, 2024

FNA

Philadelphia, Pennsylvania--(Newsfile Corp. - November 24, 2024) - A securities class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE: FNA). The lawsuit has been filed on behalf of purchasers of Paragon 28 securities between May 5, 2023 and September 20, 2024, inclusive (the "Class Period").

CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT.

Investors who purchased or acquired PARAGON 28 securities during the Class Period may, no later than NOVEMBER 29, 2024, seek to be appointed as a lead plaintiff representative of the class.

Paragon 28, headquartered in Englewood, Colorado, describes itself as a company that "develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace."

According to the lawsuit, Defendants misled investors throughout the Class Period as to the fact that: (i) Paragon 28's financial statements were misstated; and (ii) Paragon 28 lacked adequate internal controls and at times understated the extent of the issues with Paragon 28's internal controls.

For additional information or to learn how to participate in this litigation, please contact Berger Montague: Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Peter Hamner at phamner@bm.net or (215) 875-3048, or CLICK HERE.

A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the Court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.

Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.

Contact:

Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
aabramowitz@bm.net

Peter Hamner
Berger Montague PC
(215) 875-3048
phamner@bm.net

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231176



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today